Page 3 - Best Lymphoma chemotherapy doctors: TOP 72 doctors

Dr. Danylesko specializes in lymphoma chemotherapy at Sheba Medical Center, providing personalized treatment plans.

• Experienced in treating various types of lymphoma
• Works with advanced chemotherapy protocols
• Focuses on patient-centric care

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Head of Hematology at Hadassah Medical Center – Professor Ben-yehuda pioneered gene therapy and bone marrow transplants for lymphoma.

• Trained at Memorial Sloan-Kettering Cancer Center in New York
• Specializes in molecular diagnostics for blood cancers
• First female Dean of Hadassah School of Medicine
• Recipient of the Healing with the Heart Award

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Prof. Dr. Serdar Bedii Omay has published 65+ scientific articles on hematology and bone marrow transplantation, with extensive training in Japan.

• Specialized in hematology at Japan's Mie Medical School
• Professor of hematology at multiple Turkish universities
• Over 36 years of experience of experience in hematology
• Author of 112 meeting papers and 34 conference presentations

Dr. Apak specializes in pediatric lymphoma chemotherapy with over 26 years of experience of experience. He heads the Pediatric Hematology-Oncology Division at Istanbul University-Cerrahpaşa.

• Expert in bone marrow transplantation and CAR T-cell therapy
• Authored 75 international publications in pediatric oncology
• Assistant editor for Turkish Pediatrics Archives Periodical
• Board member of Turkish Pediatric Society and Turkish Adolescent Association

Prof. Dr. Rafet Eren is an Associate Professor in Hematology with 50+ publications and research awards in lymphoma and hematologic oncology.

• Specializes in hematology with a PhD focused on lymphoma treatments
• Member of European Society of Hematology and Turkish Hematology Association
• Won multiple awards for hematologic oncology research
• Fluent in English for international patient consultations

Dr. Omer Dogru specializes in pediatric hematology and oncology, with extensive training in lymphoma chemotherapy and bone marrow transplantation.

• Board-certified pediatric hematology specialist with over 20 years of experience of experience
• Trained at Hacettepe University and Istanbul University – top medical schools in Turkey
• Member of EBMT (European Bone Marrow Transplantation) and Turkish Society of Hematology
• Has worked in bone marrow transplant units at leading hospitals
• Holds academic positions at major Turkish universities

Specializes in lymphoma treatment with 36 years of experience of hematology experience. Currently practices at Liv Hospital Ulus.

• Board-certified hematologist with expertise in Hodgkin's and non-Hodgkin's lymphoma
• Published 32 articles in international peer-reviewed journals
• Member of Turkish Society of Hematology and board member of The Society of Hematological Education and Research
• Completed specialized training at ESCCA Summer School On Cytometry in Prague

Prof. Baytan specializes in childhood cancers, including lymphoma, with over 34 years of experience of experience in pediatric hematology.

• Published 15 articles in international refereed journals
• Authored 3 books or book chapters on pediatric hematology
• Expert in leukemia and lymphoma treatments for children
• Assistant Professor in Pediatric Hematology at Uludağ University

Dr. Shaunak Valame specializes in lymphoma chemotherapy with expertise in targeted therapies and molecular cancer research. Presented groundbreaking stomach cancer research at ASCO's Gastrointestinal Cancer Symposium.

• Completed DNB in Medical Oncology from Indraprastha Apollo Hospital
• Senior Residency in Internal Medicine with teaching roles at AIIMS
• Registrar experience at Jawaharlal Nehru Cancer Hospital
• Focused on molecular basis of cancer for personalized treatment

Leads the Hematology & Pediatric Oncology Unit at HM Hospitales – a top expert in pediatric lymphoma care with 31 years of experience of experience.

• Specializes in diagnostics and treatment of hematological disorders
• Consultant for WHO and UNESCO on pediatric oncology
• Head of two foundations supporting children with severe health problems
• Member of the American Society of Hematology and other prestigious organizations

10,000+ major surgeries over 15 years of experience – Dr. Banswal specializes in minimally invasive cancer surgeries at HCG Manavata Cancer Centre.

• Fellowship in Surgical Oncology from Tata Medical Centre, Kolkata
• Special focus on gastrointestinal cancer treatments
• Co-principal investigator in multiple oncology research projects
• Published in national and international medical journals

Dr. Kaya is an Associate Professor specializing in hematology and stem cell transplants, with extensive experience in lymphoma treatment.

• Trained at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
• Recipient of multiple awards for hematologic oncology research
• Member of several prestigious hematology societies
• Skilled in apheresis and stem cell transplantation

Dr. Girish Badarkhe specializes in lymphoma chemotherapy, with over 16 years of experience of experience in hematologic malignancies.

• Expertise in leukemia, multiple myeloma, and bone marrow transplants
• Board-certified with DM in Clinical Hematology from Medical College, Calcutta
• MBBS from Grant Medical College and Sir JJ Hospital
• Recognized with awards for professional excellence

30 years of experience of experience with 50,000+ cancer surgeries – Dr. Nagarkar focuses on improving quality of life post-treatment.

• Trained at Tata Memorial Hospital and Royal College of Surgeons, Edinburgh
• Specializes in Breast and Thoracic Surgical Oncology
• Involved in 200+ clinical trials from phase 1-3
• Professor for DNB Superspecialty Surgical Oncology

Professor Itir Sirinoglu Temiz focuses on lymphoma and hematologic cancers, with years of leadership in hematology units and stem cell transplantation.

• Specializes in lymphoma, leukemias, and multiple myeloma treatments
• Extensive experience in stem cell transplantation and therapeutic apheresis
• Former administrative and education manager at leading hematology clinics
• Professor with academic roles at multiple university hospitals